Putin calls Argentine leader with COVID despite Sputnik shot
Russian President Vladimir Putin has called his Argentine counterpart, who has tested positive for COVID-19 despite receiving the Russian vaccine
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.President Vladimir Putin on Monday called his Argentine counterpart, who has tested positive for COVID-19 despite receiving a Russian vaccine.
The Kremlin said in its readout of the call that Argentine President Alberto Fernández told Putin that he only had minor symptoms thanks to receiving the Sputnik V vaccine. Fernández thanked Russia for offering assistance in fighting the coronavirus and expressed interest in getting additional supplies of the Russian vaccine, according to the Kremlin statement.
Putin congratulated Fernández, who turned 62 on Friday, on his birthday and wished him a quick recovery.
In a tweet Saturday, Fernández said he had a headache and was experiencing a fever of 37.3 Celsius (99.1 Fahrenheit). He said he otherwise has slight symptoms, is isolating and is “physically well.”
The Argentine president received a dose of Sputnik V on Jan. 21 and a second dose a few days later.
The Russian Gamaleya Institute, which produced the vaccine, tweeted that it wished the president a quick recovery, and said the vaccine has a 91.6% rate of effectiveness against infection and 100% against critical cases.
More than 650,000 people in Argentina have received both scheduled shots of the vaccine and only about 1,000 of those have been found to be infected more than 14 days after the final dose, according to national health statistics.
None of the vaccines used against the new coronavirus completely eliminate infections, though they have been shown to sharply reduce the rate of infection and its severity.
___
Follow AP’s pandemic coverage at:
https://apnews.com/hub/coronavirus-pandemic
https://apnews.com/hub/coronavirus-vaccine
https://apnews.com/UnderstandingtheOutbreak